REDUCE-IT Reveals High Dose of Pure EPA in Omega-3 Drug Cuts Risk of Cardiovascular Events

Clinical trial of icosapent ethyl finds 25 percent reduction in cardiovascular events among at-risk patients
Source: BWH News - Category: Hospital Management Source Type: news